Billable/Specific ICD-10-CM Codes - Page 346

There are 35,750 ICD-10-CM codes which are billable/specific and can be used to indicate a diagnosis for reimbursement purposes as there are no codes with a greater level of specificity under each code.

  • Z13.41 - Encounter for autism screening
  • Z13.42 - Encounter for screening for global developmental delays (milestones)
  • Z13.49 - Encounter for screening for other developmental delays
  • Z13.5 - Encounter for screening for eye and ear disorders
  • Z13.6 - Encounter for screening for cardiovascular disorders
  • Z13.71 - Encounter for nonprocreative screening for genetic disease carrier status
  • Z13.79 - Encounter for other screening for genetic and chromosomal anomalies
  • Z13.810 - Encounter for screening for upper gastrointestinal disorder
  • Z13.811 - Encounter for screening for lower gastrointestinal disorder
  • Z13.818 - Encounter for screening for other digestive system disorders
  • Z13.820 - Encounter for screening for osteoporosis
  • Z13.828 - Encounter for screening for other musculoskeletal disorder
  • Z13.83 - Encounter for screening for respiratory disorder NEC
  • Z13.84 - Encounter for screening for dental disorders
  • Z13.850 - Encounter for screening for traumatic brain injury
  • Z13.858 - Encounter for screening for other nervous system disorders
  • Z13.88 - Encounter for screening for disorder due to exposure to contaminants
  • Z13.89 - Encounter for screening for other disorder
  • Z13.9 - Encounter for screening, unspecified
  • Z14.01 - Asymptomatic hemophilia A carrier
  • Z14.02 - Symptomatic hemophilia A carrier
  • Z14.1 - Cystic fibrosis carrier
  • Z14.8 - Genetic carrier of other disease
  • Z15.01 - Genetic susceptibility to malignant neoplasm of breast
  • Z15.02 - Genetic susceptibility to malignant neoplasm of ovary
  • Z15.03 - Genetic susceptibility to malignant neoplasm of prostate
  • Z15.04 - Genetic susceptibility to malignant neoplasm of endometrium
  • Z15.09 - Genetic susceptibility to other malignant neoplasm
  • Z15.1 - Genetic susceptibility to epilepsy and neurodevelopmental disorders
  • Z15.2 - Genetic susceptibility to obesity
  • Z15.81 - Genetic susceptibility to multiple endocrine neoplasia [MEN]
  • Z15.89 - Genetic susceptibility to other disease
  • Z16.10 - Resistance to unspecified beta lactam antibiotics
  • Z16.11 - Resistance to penicillins
  • Z16.12 - Extended spectrum beta lactamase (ESBL) resistance
  • Z16.13 - Resistance to carbapenem
  • Z16.19 - Resistance to other specified beta lactam antibiotics
  • Z16.20 - Resistance to unspecified antibiotic
  • Z16.21 - Resistance to vancomycin
  • Z16.22 - Resistance to vancomycin related antibiotics
  • Z16.23 - Resistance to quinolones and fluoroquinolones
  • Z16.24 - Resistance to multiple antibiotics
  • Z16.29 - Resistance to other single specified antibiotic
  • Z16.30 - Resistance to unspecified antimicrobial drugs
  • Z16.31 - Resistance to antiparasitic drug(s)
  • Z16.32 - Resistance to antifungal drug(s)
  • Z16.33 - Resistance to antiviral drug(s)
  • Z16.341 - Resistance to single antimycobacterial drug
  • Z16.342 - Resistance to multiple antimycobacterial drugs
  • Z16.35 - Resistance to multiple antimicrobial drugs
  • Z16.39 - Resistance to other specified antimicrobial drug
  • Z17.0 - Estrogen receptor positive status [ER+]
  • Z17.1 - Estrogen receptor negative status [ER-]
  • Z17.21 - Progesterone receptor positive status
  • Z17.22 - Progesterone receptor negative status
  • Z17.31 - Human epidermal growth factor receptor 2 positive status
  • Z17.32 - Human epidermal growth factor receptor 2 negative status
  • Z17.410 - Hormone receptor positive with human epidermal growth factor receptor 2 positive status
  • Z17.411 - Hormone receptor positive with human epidermal growth factor receptor 2 negative status
  • Z17.420 - Hormone receptor negative with human epidermal growth factor receptor 2 positive status
  • Z17.421 - Hormone receptor negative with human epidermal growth factor receptor 2 negative status
  • Z18.01 - Retained depleted uranium fragments
  • Z18.09 - Other retained radioactive fragments
  • Z18.10 - Retained metal fragments, unspecified
  • Z18.11 - Retained magnetic metal fragments
  • Z18.12 - Retained nonmagnetic metal fragments
  • Z18.2 - Retained plastic fragments
  • Z18.31 - Retained animal quills or spines
  • Z18.32 - Retained tooth
  • Z18.33 - Retained wood fragments
  • Z18.39 - Other retained organic fragments
  • Z18.81 - Retained glass fragments
  • Z18.83 - Retained stone or crystalline fragments
  • Z18.89 - Other specified retained foreign body fragments
  • Z18.9 - Retained foreign body fragments, unspecified material
  • Z19.1 - Hormone sensitive malignancy status
  • Z19.2 - Hormone resistant malignancy status
  • Z20.01 - Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli)
  • Z20.09 - Contact with and (suspected) exposure to other intestinal infectious diseases
  • Z20.1 - Contact with and (suspected) exposure to tuberculosis
  • Z20.2 - Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
  • Z20.3 - Contact with and (suspected) exposure to rabies
  • Z20.4 - Contact with and (suspected) exposure to rubella
  • Z20.5 - Contact with and (suspected) exposure to viral hepatitis
  • Z20.6 - Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
  • Z20.7 - Contact with and (suspected) exposure to pediculosis, acariasis and other infestations
  • Z20.810 - Contact with and (suspected) exposure to anthrax
  • Z20.811 - Contact with and (suspected) exposure to meningococcus
  • Z20.818 - Contact with and (suspected) exposure to other bacterial communicable diseases
  • Z20.820 - Contact with and (suspected) exposure to varicella
  • Z20.821 - Contact with and (suspected) exposure to Zika virus
  • Z20.822 - Contact with and (suspected) exposure to COVID-19
  • Z20.828 - Contact with and (suspected) exposure to other viral communicable diseases
  • Z20.89 - Contact with and (suspected) exposure to other communicable diseases
  • Z20.9 - Contact with and (suspected) exposure to unspecified communicable disease
  • Z22.0 - Carrier of typhoid
  • Z22.1 - Carrier of other intestinal infectious diseases
  • Z22.2 - Carrier of diphtheria
  • Z22.31 - Carrier of bacterial disease due to meningococci
  • Z22.321 - Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureus